Herakleion - Crete, Greece
A Study of Sigvotatug Vedotin Versus Docetaxel in Previously Treated Non-small Cell Lung Cancer
Phase
3Span
212 weeksSponsor
Seagen, a wholly owned subsidiary of PfizerCholargos
Recruiting
Disitamab Vedotin With Pembrolizumab vs Chemotherapy in Previously Untreated Urothelial Cancer Expressing HER2
Phase
3Span
293 weeksSponsor
Seagen, a wholly owned subsidiary of PfizerCholargos
Recruiting
Cholargos
Recruiting
A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer
Phase
3Span
353 weeksSponsor
Seagen, a wholly owned subsidiary of PfizerPsychiko
Recruiting
1-4 of 4